Related references
Note: Only part of the references are listed.Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI
Brian C. Jung et al.
JOURNAL OF NEUROIMAGING (2016)
Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas
Julio Arevalo-Perez et al.
JOURNAL OF NEUROIMAGING (2016)
Use of CT perfusion to discriminate between brain metastases from different primaries
Mikhail B. Dolgushin et al.
CLINICAL IMAGING (2015)
Dynamic contrast-enhanced MRI of ocular melanoma
Xuyuan Jiang et al.
MELANOMA RESEARCH (2015)
Glioma: Application of Histogram Analysis of Pharmacokinetic Parameters from T1-Weighted Dynamic Contrast-Enhanced MR Imaging to Tumor Grading
S. C. Jung et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2014)
Evaluation of Microvascular Permeability with Dynamic Contrast-Enhanced MRI for the Differentiation of Primary CNS Lymphoma and Glioblastoma: Radio logic-Pathologic Correlation
P. Kickingereder et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2014)
Current approaches to the treatment of metastatic brain tumours
Taofeek K. Owonikoko et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Magnetic Resonance Perfusion Characteristics of Hypervascular Renal and Hypovascular Prostate Spinal Metastases Clinical Utilities and Implications
Atin Saha et al.
SPINE (2014)
Which drug, and when, for patients with BRAF-mutant melanoma?
Sekwon Jang et al.
LANCET ONCOLOGY (2013)
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors
Lois B. Travis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction
Marie E. Wood et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas
Benjamin M. Ellingson et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2012)
Epidemiology of Brain Metastases
Lakshmi Nayak et al.
CURRENT ONCOLOGY REPORTS (2012)
Presentation, Patterns of Care, and Survival in Patients With Brain Metastases What Has Changed in the Last 20 Years?
Carsten Nieder et al.
CANCER (2011)
Pulsatile high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer
Christian Grommes et al.
NEURO-ONCOLOGY (2011)
Stereotactic Radiosurgery for the Management of Brain Metastases
John H. Suh
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Management of brain metastases: the indispensable role of surgery
George Al-Shamy et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status
Gurpreet S. Kapoor et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Current Management of Metastatic Brain Disease
Tulika Ranjan et al.
NEUROTHERAPEUTICS (2009)
Contrast agent concentration measurements affecting quantification of bolus-tracking perfusion MRI
Fernando Calamante et al.
MAGNETIC RESONANCE IN MEDICINE (2007)
The epidemiology of second primary cancers
Lois B. Travis
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging
Bahattin Hakyemez et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2006)
Efficient method for calculating kinetic parameters using T1-weighted dynamic contrast-enhanced magnetic resonance imaging
K Murase
MAGNETIC RESONANCE IN MEDICINE (2004)
Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: Correlation with histopathology
S Cha et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases
S Kremer et al.
NEURORADIOLOGY (2003)
Share Paper
